197. Back to Basics - Metastatic Colorectal Cancer - HER2 positive disease and PI3K mutations

Podcast: Oncology for the Inquisitive Mind · Michael Fernando and Josh Hurwitz

Opublikowano: 2026-04-18

Metastatic Colorectal Cancer has a dearth of targetable mutations that have effective outcomes. This week, Michael and Josh see whether the wonder drug (trastruzumab deruxtecan) works in HER2-expressing colorectal cancer. Michael takes a more positive tone, with the recycling of aspirin to reduce recurrence risk for PI3K pathway cancers. Josh promised he will have the right audio this episode - thanks to our astute listener who told us last time! Studies discussed in this episode: ALASCCA Destiny-CRC01 For more episodes, resources and blog posts...